You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

atezolizumab

Showing 26 - 50 of 765
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HPV-Related Cervical Carcinoma, HPV-Related Malignancy, Cervical Cancer Trial (VB10.16, Atezolizumab Injection [Tecentriq],

Not yet recruiting
  • HPV-Related Cervical Carcinoma
  • +2 more
  • VB10.16
  • +2 more
  • (no location specified)
Oct 24, 2023

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Tucson (Cabozantinib + Atezolizumab)

Recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Cabozantinib + Atezolizumab
  • Tucson, Arizona
    University of Arizona Cancer Center
Dec 14, 2022

Recurrent Liver Cancer After Liver Transplantation Trial (Hepatic arterial infusion chemo + Atezolizumab and bevacizumab)

Not yet recruiting
  • Recurrent Liver Cancer After Liver Transplantation
  • Hepatic arterial infusion chemotherapy + Atezolizumab and bevacizumab
  • (no location specified)
Apr 17, 2023

Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

Completed
  • Small Cell Lung Cancer
  • atezolizumab
  • Chalon-sur-Saône, France
  • +1 more
Jan 5, 2023

Stage II Melanoma Trial in United States (Atezolizumab, Tiragolumab, Signatera Assay)

Recruiting
  • Stage II Melanoma
  • Atezolizumab
  • +2 more
  • Duarte, California
  • +5 more
Nov 10, 2022

Hepatocellular Carcinoma, Atezolizumab-bevacizumab, Response Evaluation Trial in Seoul (Early response evaluation)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Early response evaluation
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Feb 28, 2023

Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • 89Zr-atezolizumab PET/CT
  • (no location specified)
Feb 22, 2023

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced Alveolar Soft Part Sarcoma
  • +9 more
  • Atezolizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 10, 2023

Melanoma Trial in Beijing City, Fuzhou City, Zhejiang (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Melanoma
  • Beijing City, China
  • +2 more
Dec 13, 2022

Hepatocellular Carcinoma Trial in Seoul (AtezoBev with combined radiotherapy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • AtezoBev with combined radiotherapy
  • Seoul, Korea, Republic of
    Severance hospital
Jun 9, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Essen (Atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Atezolizumab
  • Essen, Germany
    University Hospital Essen
Nov 2, 2022

Endometrial Cancer, Metastasis Trial (Atezolizumab, ONC201)

Not yet recruiting
  • Endometrial Cancer
  • Metastasis
  • (no location specified)
Sep 12, 2022

Hepatocellular Carcinoma Trial (NP137, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Sep 23, 2022

Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

Recruiting
  • Urothelial Cancer
  • Atezolizumab
  • +2 more
  • Beijing, China
    Beijing Cancer Hospital
Jan 18, 2023

Atezolizumab With Nab-paclitaxel for Triple-negative Stage IV

Completed
  • Breast Cancer Metastatic
  • Atezolizumab in combination with nab-paclitaxel
  • Roma, RM, Italy
    Policlinico A. Gemelli - IRCCS
Nov 2, 2022

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Abemaciclib, Atezolizumab)

Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 26, 2022

NSCLC Trial (Atezolizumab, Tiragolumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Apr 11, 2023

NSCLC Trial in Pittsburgh (Tiragolumab, Atezolizumab, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 16, 2023

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (biological, procedure, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Atezolizumab
  • +5 more
  • (no location specified)
Feb 4, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)

Recruiting
  • Hepatocellular Carcinoma
  • Atezolizumab
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 24, 2023

Idiopathic Pulmonary Fibrosis Trial in Los Angeles (Atezolizumab)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Atezolizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Aug 23, 2022

Hepatocellular Carcinoma, NSCLC Metastatic, Liver Metastases Trial in Toronto (Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Hepatocellular Carcinoma, Cancer of Liver Trial (PXS-5505 and Atezolizumab and Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Cancer of Liver
  • PXS-5505 and Atezolizumab and Bevacizumab
  • Rochester, New York
    University of Rochester
Nov 3, 2022

HCC - Hepatocellular Carcinoma, Metastatic Cancer, Metastatic Tumor Trial in France (Ipilimumab Injection, Atezolizumab

Not yet recruiting
  • HCC - Hepatocellular Carcinoma
  • +2 more
  • Ipilimumab Injection
  • +2 more
  • Créteil, France
  • +7 more
Dec 27, 2022

Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Dendritic cell vaccination
  • +2 more
  • Edegem, Antwerp, Belgium
  • +2 more
Feb 28, 2023